Breye Therapeutics: Funding, Investors & Team (Oct 2026)
Breye Therapeutics develops oral medicines for retinal diseases, with a focus on diabetic retinopathy and age-related macular degeneration.
Breye Therapeutics has raised $76.7M across 1 funding round on record, the most recent a Series A of $76.7M announced in Sep 2026.
That round is above the $3.3M median round size for Denmark companies tracked on FundedIQ over the last two years.
Breye Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2026.
Breye Therapeutics Funding Rounds
Breye Therapeutics Investors
12 investors are recorded in total; the 5 named above are those the record identifies.
Breye Therapeutics Founders and Leadership Team
Contact details for the Breye Therapeutics team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Breye Therapeutics Funding in Context
Breye Therapeutics' latest round of $76.7M is above the median round in Denmark. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Breye Therapeutics in Biopharma and Hørsholm
Companies Similar to Breye Therapeutics
Tryp.com is a platform powered by AI that provides travel arrangements. By implementing artificial…
Onomondo is a worldwide cell administrator that offers remote organization for Internet of Things (IoT)…
Complir is a compliance platform designed for the retail sector to help businesses manage regulations and…
Sylvia Health enable prolapsed ladies to take back control of their lives.
AffinityAI ApS provides AI-powered protein binders called Designerbodies™ for research.
Copenhagen Microsystems develops 3D ice lithography systems for nanoscale additive manufacturing.
Fibernex develops nanofiber materials to optimize green hydrogen production.
KhaosGuard uses mid-infrared lasers for real-time site emissions monitoring.
3Sonic is a Med-Tech startup company that has developed a novel 3D imaging device to improve precision in…
PanTarg develops antibody-drug conjugates for pancreatic cancer and other solid tumors.
Proxi Biotech develops a bacteria-resistant vaccine to treat multi-drug-resistant bacterial infections.
Yngvi Bio develops protein-based biopesticides for targeted agricultural pest control.
Breye Therapeutics Funding FAQs
What does Breye Therapeutics do?
Breye Therapeutics develops oral medicines for retinal diseases, with a focus on diabetic retinopathy and age-related macular degeneration.
How much funding has Breye Therapeutics raised?
Breye Therapeutics has raised $76.7M across 1 round on record. The most recent is a Series A of $76.7M announced in Sep 2026.
When did Breye Therapeutics last raise funding?
Breye Therapeutics' most recent funding round on record is a Series A of $76.7M, announced in Sep 2026.
Who has invested in Breye Therapeutics?
Investors on record for Breye Therapeutics include Innovestor, Novo Holdings, BioInnovation Institute, Mission BioCapital, Sound Bioventures. FundedIQ records 12 investors in total.
Who is the CEO of Breye Therapeutics?
Ulrik Mouritzen is listed as Chief Executive Officer at Breye Therapeutics.
Where is Breye Therapeutics headquartered?
Breye Therapeutics is based in Hørsholm, Denmark.
How many employees does Breye Therapeutics have?
Breye Therapeutics is in the 11-50 employee band.
When was Breye Therapeutics founded?
Breye Therapeutics was founded in 2019.
About FundedIQ's Breye Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Breye Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.